H.R. 4605

Summary

H.R. 4605, the End Prescription Drug Ads Now Act, was introduced in the House on Jul 22, 2025 by Rep. Jerrold Nadler (D) with 3 co-sponsors. It was referred to Energy And Commerce, and last saw action on Jul 22, 2025: Referred to the House Committee on Energy and Commerce.

Record

Text

H.R. 4605 has 3 co-sponsors.

119 HR 4605 IH: End Prescription Drug Ads Now Act
 U.S. House of Representatives
 2025-07-22
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 4605  IN THE HOUSE OF REPRESENTATIVES   July 22, 2025   Mr. Nadler  (for himself and  Ms. Dexter ) introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products.
1.
Short title
This Act may be cited as the   End Prescription Drug Ads Now Act  .
2.
Prohibition on direct-to-consumer drug advertising of drugs
(a)
In general
Section 502 the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by adding at the end the following:
(hh)
(1)
If it is a drug approved under section 505 or licensed under section 351 of the Public Health Service Act, and subject to section 503(b)(1), and the holder of the approved application under section 505 or of the license under such section 351 has conducted direct-to-consumer advertising of the drug within the most recent 30-day period.
(2)
For purposes of this paragraph, the term  direct-to-consumer advertising , with respect to a drug subject to section 503(b)(1), means any promotional communication targeting consumers, including through television, radio, print media, digital platforms, and social media, for purposes of marketing such a drug.
 .
(b)
Effective date
The amendment made by subsection (a) shall take effect 30 days after the date of enactment of this Act, and shall apply with respect to any drug approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) or licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ), regardless of when the drug was approved or licensed.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

To ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products.

Sponsors

Rep. Jerrold Nadler (D) sponsors H.R. 4605, and 3 members have co-sponsored it, 1 of them from the day it was introduced.

Jerrold Nadler

Rep. · D–NY-12 · Sponsor

Introduced Jul 22, 2025

Maxine Dexter

Rep. · D–OR-3 · Co-sponsor

Joined Jul 22, 2025 · Original

Ilhan Omar

Rep. · D–MN-5 · Co-sponsor

Joined Jul 23, 2025

Rashida Tlaib

D–MI-12 · Co-sponsor

Joined Sep 2, 2026

Show 4 of 4 rows

PreviousNext

Committees

H.R. 4605 went before 1 committee: Energy and Commerce.

Energy and Commerce

Energy and Commerce

Referred To · Jul 22, 2025 · 1,636 Bills

Actions

H.R. 4605 has taken 2 actions since Jul 22, 2025.

Votes

H.R. 4605 has not gone to a roll call.

Related bills

1 bill is related to H.R. 4605, as Identical bill.

S 2068End Prescription Drug Ads Now ActJun 12, 2025 · Read twice and referred to the Committee on Health, Education, Labor, and Pensi… · Identical bill

Show 1 of 1 row

PreviousNext

Titles

H.R. 4605 goes by 3 titles, 1 of them short titles.

• End Prescription Drug Ads Now Act — Display Title
• To ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products. — Official Title as Introduced
• End Prescription Drug Ads Now Act — Short Title(s) as Introduced

Lobbying

3 clients hired 3 firms and 21 registered lobbyists who named H.R. 4605 in 12 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Insurance, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code.

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 21.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files H.R. 4605 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 4605’s is Health.

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 4605, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 125 (Tuesday, July 22, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. NADLER:H.R. 4605.Congress has the power to enact this legislation pursuantto the following:Congress has the power to enact this legislation pursuantto section 8 of article I of the Constitution.[Page H3554]

Source: congress.gov · legiscan.com